Tag: pharmaceuticals
-
Infographic — World’s Biggest Players in Pharma
The following chart shows the top 10 pharmaceutical companies ranked by prescription drug product sales, in green, and research spending, in red.
-
FDA Approves Sickle Cell Drug
The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels.
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
Glaxo Using Artificial Intelligence for Drug Discovery
Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets.
-
NIH Funds Nanotech Tools for Cancer, Blood Clots
A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.
-
Flu Vaccine Patch Shown Safe, Responsive
A patch to deliver flu vaccine with tiny painless needles worn like a band-aid was shown in a clinical trial to be safe and produce an immune response.
-
Preclinical Data Show Promise for Diabetic Eye Drug
Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
Long-Acting Drug Blocks Opioid Effects, Withdrawal
Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms.